CGRP-A2 radioligand agent (Merck)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameCGRP-A2 radioligand agent (Merck)
Drug Alias Name[3H]-CGRP-A2 radioligand (Merck)Tritium-CGRPA23H-CGRPA2CGRPA2-[3H]
ClassificationRadiation-emitting products > Radioactive diagnostic agentDiagnostic agent (In vivo)Small molecules
Mechanisms of ActionCalcitonin gene-related peptide receptor agonistsPositron-emission tomography enhancers
TargetsCalcitonin gene-related peptide receptor
Therapy Area/IndicationsMigraine Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Research Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Research Laboratories
Active IndicationsN/A
Inactive IndicationsMigraine Disorders

Other Information

ATC CodeN/A
Related LinksN/A